Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them.
Latigo Biotherapeutics
1 follower
Thermo Fisher Scientific
289 followers
Genentech
228 followers
Gilead Sciences
218 followers
Regeneron
187 followers
Biogen
168 followers
Vertex Pharmaceuticals
115 followers
Agilent Technologies
102 followers
Neuralink
92 followers
BioMarin Pharmaceutical
60 followers
Alexion Pharmaceuticals
58 followers
Verily Life Sciences
49 followers